Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Bayer Schering Pharma Presents Positive Results Of Phase II Study With Riociguat
Positive data from a

Oakland, Calif., Conference Targets Black Women For HIV/AIDS Awareness, Prevention
The Oakland, Calif., chapter of the National Coalition of 100 Black Women on Saturday held a daylong conference, "Sistahs Getting Real About HIV/AIDS," that addressed HIV/AIDS among black women, the San Francisco Chronicle reports. The conference "focused on two issues that might seem contradictory: first, to convince women that they must take special precautions to protect themselves, and second, to let them know that an HIV diagnosis is not a death sentence," according to the Chronicle. Keynote speaker of the conference Tony Wafford, director of health and wellness for the National Action Network, said black women need to be more vocal with their partners about practicing safe sex and getting tested for HIV. Organizers noted that black women also "must address the stigma associated with HIV before they can talk openly about the risk of infection with their partners," the article states (Allday, 7/25).
News of the day
CEL-SCI Developing Immune-Based Treatment Against Swine And Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology
CEL-SCI Corporation (NYSE AMEX: CVM) announced that it is developing an immune-based treatment for the "swine flu and related H1N1" flu viruses, utilizing its proprietary L.E.A.P.S.(TM) (Ligand Epitope Antigen Presentation System) vaccine technology. The Company plans to utilize the expertise and knowledge it has gained from developing protective and therapeutic vaccines utilizing L.E.A.P.S. to develop a therapeutic treatment based upon the technology for people infected with the swine and H1N1 flu viruses. CEL-SCI has already commenced pre-clinical testing.
Sexual Health

Breast MRI Detects Additional "Unsuspected" Cancers Not Seen On Mammography Or Ultrasound

Nearly 20% of patients with recently diagnosed breast cancer had additional malignant tumors found only by MRI, according to a study performed at Dartmouth Hitchcock Medical Center. A total of 199 patients with newly diagnosed breast cancer underwent breast MRI. "We found additional, unsuspected cancers in the ipsilateral breast (the one that had already been diagnosed with cancer) in 16% of patients; we found cancers in the contralateral breast (the one that had not been diagnosed with cancer) in 4% of patients," said Petra J. Lewis, MD, lead author of the study. "These patients had already had bilateral mammography and these tumors had not been apparent on mammography," said Dr. Lewis. "The detection of an unsuspected tumor is critical. These additional tumors in nearly a fifth of patients are tumors that can potentially grow and not be diagnosed until they are much larger affecting the health and survival of the patients," she said. "This study has been particularly helpful to us as clinicians because it gives us data we can discuss with patients when recommending breast MRI," said Dr. Lewis. This study appears in the May issue of the American Journal of Roentgenology. About ARRS The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Its monthly journal, the American Journal of Roentgenology, began publication in 1906. Radiologists from all over the world attend the ARRS annual meeting to participate in instructional courses, scientific paper presentations and scientific and commercial exhibits related to the field of radiology. The Society is named after the first Nobel Laureate in Physics, Wilhelm Rē¶entgen, who discovered the x-ray in 1895. American Roentgen Ray Society (ARRS)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009